Vous êtes sur la page 1sur 10

About Us

Rajasthan Antibiotics Ltd. (RAL) commenced commercial production in 1991 and has grown in size and stature to become the country's largest producer of the injectable antibiotics. Besides being the first company to produce Ampicillin Sodium Sterile, RAL also pioneered the manufacturer of Omeprazole Sodium Sterile in India, for which it has won worldwide acceptance.

History

Rajasthan Antibiotics Limited (RAL) was incorporated in the year RAL is a fast track integrated pharmaceutical company which commenced its commercial production in 1991 and has grown in size and stature to become the country's one of the largest producers of the Sterile APIs (Active Pharmaceutical Ingredients). Besides being the first company to produce Ampicillin Sodium Sterile, RAL also pioneered the manufacturing of Sterile Anti Ulcer drugs namely Omeprazole Sodium Sterile & Pantaprazole Sodium Sterile, for which it has won worldwide acceptance.

Global Presence

The Company has a well established clientele in India as well as several other countries like Europe, China, Brazil, Indonesia, Bangladesh and UAE. The company now has five Lyophilizers and Crystalline Plant to manufacture Sterile APIs. Currently these are the only 2 technologies available in the international market which are required to manufacture sterile bulk drugs and the Company has implemented both the technologies at its plant located at Bhiwadi, Rajasthan (India)

Mission
Our expertise and our products are helping to diagnose, alleviate or cure diseases, improving the quality and adequacy of the PEOPLE's LIVES,

and contributing significantly to an active, modern lifestyle. We are committed to the principles of sustainable development and to our role as a socially and ethically responsible corporate citizen. For us, there is a clear link between technical and economic expertise and our responsibility to work for the benefit of humankind, become socially involved and make a lasting contribution to sustainable development. At RAL, we regard economy, ecology and social commitment as objectives of equal rank. We seek to retain society's confidence through performance, flexibility and open communication as we work in

pursuit of our overriding goals: to steadily create corporate value and generate high value-added for the benefit of our Stake Holder, our employees and the community in every country in which we operate.

Vision
To be one of the worlds' leading and most admired API and pharmaceutical companies in the global Pharmaceuticals and API industry in sphere of excellence manufacturing, innovation, formulation, marketing and to escalate the business from threshold of country and to become a forerunner in overseas. For the healthy tomorrow we improve lives by

providing economical products to our customers and end-users. Our main motto is to become number one Pharma Company in the world and To preserve earth's most precious resource. Human lives. To fulfill our vision our every persons in this organization work very hard to become the best recognized Pharma Company in the world.
Products Portfolio

Sterile API

Sterile Penicillins Proton Pump Inhibitors Carbapenem's Products Under Development

General Formulations

Phytochemicals

Thiocolchicoside Green Coffee BeanExtract 45% & 50% Reserpine Vinpocetine Raubascine Yohimbine HCL 98% & 8% Colchicine 5-hydroxy-tryptophan (5-HTP) 10 DAB III Irvingia Vincamine

Quinine Sulphate

Facillities

RAL operates two dedicated manufacturing facilities for manufacturing Sterile Products as under:

Site 1
(EU / ANVISA Approvable) : Sterile Lyophilized PPI'S, General Lyophilized API & Vials, Dry Powder Vials, this site is ready for EU GMP Inspections.

Site 2
(WHO GMP Approved) : Sterile Penicillin's & Penems for ROW markets.

Research & Development


Research & Development is the foundation of RAL's philosophy of developing cost-effective, high quality and safe medicines to society. RAL Research Foundation is one of the most innovative, productive, and respected scientific research organizations. Rajasthan Antibiotics Research Foundation (RRF) has a team of over 20 dedicated scientists working in the areas of Process, Analytical and Discovery Research. R & D centre conforms to international standards and has advanced equipment for both basic and applied research.

Process R&D
RRF has developed process for different molecules for various markets. The R&D team actively involved in process development, scaling-up technology transfer and associates with manufacturing team throughout life cycle of product.

RRF has always been emphasizing to ensure that the processes being adopted for the products are cost effective, safe to handle and with optimum advantage in terms of yield and quality.

Analytical R&D
Analytical research at RRF is equipped to conduct complete physical and chemical characterisation of API's. Further, the team is well versed with regulatory filings and has vast experience in documentation. The infrastructure includes advanced instruments like LC-MS-MS, GC-MS, NMR, and Powder XRD apart from several HPLC systems.

Product research
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been theindustry's standard dummy text ever since the 1500s

Quality
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been theindustry's standard dummy text ever since the 1500s

Vous aimerez peut-être aussi